{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "31.11",
    "chg": -0.36,
    "chgp": "-1.14%",
    "dir": -1,
    "prev_price": "31.47",
    "mcapval": "52.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE584F01014",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "1.99 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/mangalam-drugs-138636-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Mangalam Drugs and Organics reports consolidated net loss of Rs 7.64 crore in the June 2026 quarter",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-08-13 09:13:50",
        "description": "Mangalam Drugs and Organics reports consolidated net loss of Rs 7.64 crore in the June 2026 quarter  Business Standard..."
      }
    ],
    "total": 1,
    "sid": "138636",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Oct-2026",
      "details": "Intimation of Certificate received from RTA i.e. MUFG Intime India Private Limited under Regulation 74(5) of DP 2018 for the quarter ended September 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "03-Oct-2026",
      "details": "Intimation under Regulation 30 of SEBI (LODR)2015 for Newspaper publication regarding issuance of postal ballot notice for appointment of Mr. Prabhakar Raghunath Zavar as Independent Director.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "01-Oct-2026",
      "details": "Approval for the appointment of Shri Prabhakar Raghunath Zavar as an Independent Director (Non Executive Director) of the Company for term of 5 years who has attained age of 78 years.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mangalam Drugs and Organics reports consolidated net loss of Rs 7.64 crore in the June 2026 quarter

2026-08-13 09:13:50

Mangalam Drugs and Organics reports consolidated net loss of Rs 7.64 crore in the June 2026 quarter Business Standard...

Read More

View All News